Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bandebereho Father Groups: a Randomized Control Trial to Assess the Impact of Maternal, Newborn and Child Health Group Education for New and Expecting Fathers

NCT02694627 is registered in ClinicalTrials.gov with Promundo, United States as lead sponsor.

NCT NCT02694627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02694627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bandebereho Father Groups: a Randomized Control Trial to Assess the Impact of Maternal, Newborn and Child Health Group Education for New and Expecting Fathers
Lead sponsor
Promundo, United States
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2015
Completion date
January 31, 2017
Enrollment
2,400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

contraception, gender relations, partner communication, prenatal care, violence